150 related articles for article (PubMed ID: 23806383)
1. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice.
Marshall D; Laberge JM; Firetag B; Miller T; Kerlan RK
J Vasc Interv Radiol; 2013 Aug; 24(8):1094-103. PubMed ID: 23806383
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology in interventional radiology.
Abi-Jaoudeh N; Duffy AG; Greten TF; Kohn EC; Clark TW; Wood BJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1083-92; quiz 1093. PubMed ID: 23885909
[TBL] [Abstract][Full Text] [Related]
3. Epistatic interactions and drug response.
Weigelt B; Reis-Filho JS
J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
[TBL] [Abstract][Full Text] [Related]
4. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Devarakonda S; Morgensztern D; Govindan R
Oncology (Williston Park); 2013 Sep; 27(9):899-906. PubMed ID: 24282988
[TBL] [Abstract][Full Text] [Related]
6. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
7. PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E
Expert Opin Pharmacother; 2013 Apr; 14(5):597-608. PubMed ID: 23472711
[TBL] [Abstract][Full Text] [Related]
8. Genomics, personalized medicine and cancer practice.
Dancey J
Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
[No Abstract] [Full Text] [Related]
9. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
[TBL] [Abstract][Full Text] [Related]
10. Somatic alterations as the basis for resistance to targeted therapies.
Blair BG; Bardelli A; Park BH
J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
[TBL] [Abstract][Full Text] [Related]
11. Molecular prognostication of non-small cell lung cancer.
Tsao MS; Jablons DM
Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
[No Abstract] [Full Text] [Related]
12. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
13. Biology-driven phase II trials: what is the optimal model for molecular selection?
Andre F; Delaloge S; Soria JC
J Clin Oncol; 2011 Apr; 29(10):1236-8. PubMed ID: 21343554
[No Abstract] [Full Text] [Related]
14. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
15. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
[TBL] [Abstract][Full Text] [Related]
16. Improving evidence developed from population-level experience with targeted agents.
McClellan MB; Daniel GW; Dickson D; Perlmutter J; Berger DP; Miller V; Nussbaum S; Malin J; Romine MH; Schilsky RL
Clin Pharmacol Ther; 2015 May; 97(5):478-87. PubMed ID: 25676878
[TBL] [Abstract][Full Text] [Related]
17. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
18. Personalized oncology: genomic screening in phase 1.
Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing applications in cancer research.
Zhang W; Nykter M; Chen K
Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
[No Abstract] [Full Text] [Related]
20. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]